title: DNA repair after irradiation in glioma cells and normal human astrocytes.
abstract: We examined DNA damage responses and repair in four human glioma cell lines (A7, U87, T98G, and U373) and normal human astrocytes (NHAs) after clinically relevant radiation doses to establish whether we could identify differences among them that might suggest new approaches to selective radiosensitization. We used phosphorylation of histone H2AX visualized by immunocytochemistry to assess DNA double-strand break (DSB) formation and resolution. Fluorescence immunocytochemistry was used to visualize and quantify repair foci. Western blotting was used to quantify repair protein levels in the different cell lines before and after irradiation and during different cell cycle phases. Mitotic labeling was used to measure cell cycle parameters after irradiation. We found that the glioma cell lines repaired DSBs more slowly and less effectively than did NHAs in the clinically relevant dose range, as assessed by induction and resolution of H2AX phosphorylation, and this was most marked in the three TP53-mutated cell lines (T98G, A7, and U373). The glioma cells also expressed relatively high repair-protein levels compared with NHAs that were not altered by irradiation. High levels of the repair protein Rad51 in these cells persisted throughout the cell cycle, and a marked increase in Rad51 foci formation, which was not restricted to cells in G2/S phase, occurred at early time points after irradiation. TP53-mutated glioma cell lines demonstrated a very prominent dose-responsive G2 checkpoint and were sensitized to radiation by caffeine, which inhibits G2/S phase checkpoint activation. In conclusion, DNA repair events differed in these four glioma cell lines compared with NHAs. In particular, the three TP53-mutated glioma cell lines exhibited markedly increased Rad51 protein levels and marked, dose-dependent Rad51 foci formation after low radiation doses. This suggests that agents that disrupt Rad51-dependent repair or prevent G2 checkpoint activation may selectively sensitize these cells.
authors: Department of Oncology, University College London, 250 Euston Rd., London NW1 2PG, UK. s.short@ucl.ac.uk
authors: Susan C
authors: SC
authors: Short
authors: Christine
authors: C
authors: Martindale
authors: Sara
authors: S
authors: Bourne
authors: Geoff
authors: G
authors: Brand
authors: Mick
authors: M
authors: Woodcock
authors: Peter
authors: P
authors: Johnston
mesh_terms: D001253:Astrocytes / Q000528:radiation effects*; D015153:Blotting, Western; D002453:Cell Cycle / Q000235:genetics / Q000528:radiation effects; D045744:Cell Line, Tumor; D053903:DNA Breaks, Double-Stranded / Q000528:radiation effects*; D004260:DNA Repair / Q000235:genetics* / Q000528:radiation effects*; D004307:Dose-Response Relationship, Radiation; D005455:Fluorescent Antibody Technique; D005910:Glioma / Q000235:genetics*; D006801:Humans; D051135:Rad51 Recombinase / Q000096:biosynthesis / Q000528:radiation effects; D011836:Radiation Tolerance / Q000502:physiology*
chemical_list: D051135:Rad51 Recombinase
references: J Cell Biol. 2005 Aug 1;170(3):341-7
references: 16061690
references: Nature. 2005 Mar 31;434(7033):598-604
references: 15800615
references: Cancer Lett. 2005 Nov 18;229(2):171-9
references: 16129552
references: Br J Cancer. 2005 Oct 31;93(9):1011-8
references: 16249792
references: Nature. 2006 Jan 26;439(7075):497-501
references: 16299494
references: Int J Cancer. 2006 Dec 15;119(12):2784-94
references: 17019715
references: Am J Pathol. 2007 May;170(5):1445-53
references: 17456751
references: J Neurosurg. 1999 Dec;91(6):997-1004
references: 10584846
references: Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1109-15
references: 10613302
references: Int J Radiat Biol. 1999 Dec;75(12):1589-95
references: 10622265
references: Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):779-84
references: 10837964
references: Curr Biol. 2000 Jul 27-Aug 10;10(15):886-95
references: 10959836
references: Cancer Res. 2002 Jan 1;62(1):219-25
references: 11782381
references: Cancer Res. 2003 May 15;63(10):2596-605
references: 12750285
references: Nat Cell Biol. 2003 Jul;5(7):675-9
references: 12792649
references: Toxicology. 2003 Nov 15;193(1-2):91-109
references: 14599770
references: Cancer Res. 2003 Nov 1;63(21):7377-83
references: 14612536
references: DNA Repair (Amst). 2004 Feb 3;3(2):113-20
references: 14706344
references: Cancer Res. 2005 May 15;65(10):4368-75
references: 15899829
references: Mutat Res. 2005 Jul 1;574(1-2):22-33
references: 15914204
references: Clin Cancer Res. 2005 Jun 15;11(12):4444-50
references: 15958629
references: J Biol Chem. 2004 Apr 9;279(15):15402-10
references: 14744854
references: J Mol Biol. 2004 Feb 20;336(3):639-54
references: 15095978
references: Science. 1995 Feb 24;267(5201):1183-5
references: 7855602
references: Oncol Res. 1994;6(10-11):509-18
references: 7620219
references: Mol Gen Genet. 1996 Apr 24;251(1):1-12
references: 8628240
references: Anticancer Drugs. 1997 Jan;8(1):92-7
references: 9147618
references: J Biol Chem. 1998 Mar 6;273(10):5858-68
references: 9488723
references: Biochem Biophys Res Commun. 1998 Apr 17;245(2):319-24
references: 9571148
references: Nucleic Acids Res. 1998 Jun 15;26(12):2859-64
references: 9611228
references: Int J Radiat Biol. 1999 Jul;75(7):847-55
references: 10489896
references: Am J Clin Oncol. 2005 Feb;28(1):43-50
references: 15685034
references: N Engl J Med. 2005 Mar 10;352(10):987-96
references: 15758009
references: N Engl J Med. 2005 Mar 10;352(10):997-1003
references: 15758010
references: Radiat Res. 2005 Sep;164(3):292-302
references: 16137202